Past Issues

• 8

  Advanced Therapies For Patients Suffering From PAH

  Shola Oyewole, CIO, United Therapeutics Corporation [NASDAQ:UTHR]

• 12

  Like A Tailored Suite: Producing Customized Viral Vectors That Respond To Market Demands

  Giuliana Vallanti, Director, Development and Global R&D Cell and Gene, Margherita Neri, Vector Process Development Manager, Anna Stornaiuolo, AGC Biologics

• 19

  Molecular Devices Challenges and Trends in the Sythetic Biology Space

  Dan O’Connor, VP Drug Discovery, Western Markets, Molecular Devices

• 24

  Challenges And Opportunities For Ai In Drug Discovery

  Robert J Prill, Director, Data Science and AI, Computational Biology and Data Sciences, Ferring Pharmaceuticals and Yong Yue, Senior Director, Computational Biology and Data Sciences, Ferring Pharmaceuticals

• 26

  The World Of Omnichannel Comes to Life Sciences: What Digital Transformation Looks Like in the Pharma Industry

  Paul R. Whitacre, PMP, Associate Director, Digital Excellence, Commercial Strategy & Operations Astellas Pharma US, Inc.

• 28

  Accelerating Drug Development Of Novel Targeted Therapies Through Histology-Agnostic Oncology Clinical Trials

  Hua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker, Zai Lab

• 30

  Cloud Computing for Affordable Medicines

  Manoj Shah, VP, IT and Business Support, Amneal Pharmaceuticals (NYSE: AMRX)